Definitive Healthcare Corp (DH)
NASDAQ:DH
Want to see DH full AI Analyst Report?
DH Stock Chart & Stats
$1.03
-$0.06(-1.41%)
At close: 4:00 PM EST
$1.03
-$0.06(-1.41%)
Day’s Range― - ―
52-Week Range$0.90 - $4.70
Previous CloseN/A
Volume69.97K
Average Volume (3M)338.90K
Market Cap
$140.84M
Enterprise Value$117.22M
Total Cash (Recent Filing)$180.89M
Total Debt (Recent Filing)$177.82M
Price to Earnings (P/E)―
Beta1.53
Next Earnings
May 07, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding104,472,374
10 Day Avg. Volume311,870
30 Day Avg. Volume338,897
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)1.09
Price to Sales (P/S)1.27
P/FCF Ratio8.26
Enterprise Value/Market Cap0.83
Enterprise Value/Revenue0.49
Enterprise Value/Gross Profit0.64
Enterprise Value/Ebitda-0.80
Forecast
1Y Price Target
$2.63Price Target Upside155.20% Upside
Rating ConsensusHold
Number of Analyst Covering10
EPS Forecast (FY)0.17
Revenue Forecast (FY)$223.64M
Bulls Say, Bears Say
Bulls Say
Customer Retention ImprovementImproved gross revenue retention and a meaningful rise in gross dollar retention indicate the customer base is stabilizing, which could make revenue more predictable and support a valuation re-rating if sustained.
Financial Results And Investor CommunicationReported revenue and adjusted profitability exceeded expectations and CFO engagement at a major investor conference underscores management's focus on transparent communication, which could boost investor confidence.
Product And Data EnhancementsPlatform innovations, the addition of a new claims data source, and diversification of data providers have improved data quality and expanded integrations, increasing appeal to enterprise clients and supporting potential upsell opportunities.
Bears Say
Fixed-cost Pressure And Weak GuidanceA high fixed-cost structure combined with forward guidance below analysts' consensus increases pressure on profitability and could magnify downside if revenue growth remains sluggish.
Revenue Decline And Turnaround UncertaintyRevenue is declining and management expects further decreases, leaving the timing of a sustainable turnaround unclear and creating downside risk for the stock.
Weak Upsell And Resumed ChurnWeak upsell and cross-sell performance, coupled with resumed customer churn after renewals, limits organic growth and threatens progress on net dollar retention.
Definitive Healthcare Corp News
DH FAQ
What was Definitive Healthcare Corp’s price range in the past 12 months?
Definitive Healthcare Corp lowest stock price was $0.90 and its highest was $4.70 in the past 12 months.
What is Definitive Healthcare Corp’s market cap?
Definitive Healthcare Corp’s market cap is $140.84M.
When is Definitive Healthcare Corp’s upcoming earnings report date?
Definitive Healthcare Corp’s upcoming earnings report date is May 07, 2026 which is in 3 days.
How were Definitive Healthcare Corp’s earnings last quarter?
Definitive Healthcare Corp released its earnings results on Feb 26, 2026. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.061 by -$0.001.
Is Definitive Healthcare Corp overvalued?
According to Wall Street analysts Definitive Healthcare Corp’s price is currently Undervalued.
Does Definitive Healthcare Corp pay dividends?
Definitive Healthcare Corp does not currently pay dividends.
What is Definitive Healthcare Corp’s EPS estimate?
Definitive Healthcare Corp’s EPS estimate is 0.03.
How many shares outstanding does Definitive Healthcare Corp have?
Definitive Healthcare Corp has 104,472,374 shares outstanding.
What happened to Definitive Healthcare Corp’s price movement after its last earnings report?
Definitive Healthcare Corp reported an EPS of $0.06 in its last earnings report, missing expectations of $0.061. Following the earnings report the stock price went down -8.571%.
Which hedge fund is a major shareholder of Definitive Healthcare Corp?
Currently, no hedge funds are holding shares in DH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Definitive Healthcare Corp Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$2.63 (155.20% Upside)
$2.63 (155.20% Upside)
Hedge Fund Trend
Increased
By 63.9K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.79%
12-Months-Change
Fundamentals
Return on Equity
-46.61%
Trailing 12-Months
Asset Growth
-32.49%
Trailing 12-Months
Company Description
Definitive Healthcare Corp
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
DH Company Deck
DH Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed but stabilizing picture: strong profitability, cash generation and operational progress (claims data remediation, faster integrations, digital activation traction and AI roadmap) are meaningful positives, while top-line weakness, reduced multi-year contract durations, and soft net dollar retention/upsell pressure continue to weigh on near-term growth. Management guided conservatively for 2026 with continued investment in product and integrations and expects NDR and revenue to improve later in the year as those investments and data fixes take hold.View all DH earnings summariesDH Stock 12 Month Forecast
Average Price Target
$2.63
▲(155.20% Upside)
Technical Analysis
Ownership Overview
12.39% Insiders
4.07% Mutual Funds
0.68% Other Institutional Investors
77.64% Public Companies and
Individual Investors